A detailed history of State Of New Jersey Common Pension Fund D transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 42,421 shares of APLS stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,421
Previous 53,064 20.06%
Holding current value
$1.48 Million
Previous $3.18 Million 21.51%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$55.39 - $72.47 $589,515 - $771,298
-10,643 Reduced 20.06%
42,421 $2.49 Million
Q4 2023

Feb 02, 2024

SELL
$37.14 - $64.82 $314,092 - $548,182
-8,457 Reduced 13.75%
53,064 $3.18 Million
Q3 2023

Nov 08, 2023

BUY
$23.65 - $89.22 $244,257 - $921,464
10,328 Added 20.17%
61,521 $2.34 Million
Q2 2023

Aug 02, 2023

SELL
$76.68 - $93.31 $299,205 - $364,095
-3,902 Reduced 7.08%
51,193 $4.66 Million
Q1 2023

Apr 26, 2023

SELL
$46.59 - $66.96 $130,824 - $188,023
-2,808 Reduced 4.85%
55,095 $3.63 Million
Q4 2022

Feb 01, 2023

BUY
$43.24 - $61.04 $132,703 - $187,331
3,069 Added 5.6%
57,903 $2.99 Million
Q3 2022

Oct 28, 2022

BUY
$44.76 - $69.66 $178,637 - $278,013
3,991 Added 7.85%
54,834 $3.75 Million
Q2 2022

Aug 04, 2022

SELL
$35.07 - $59.21 $293,991 - $496,357
-8,383 Reduced 14.15%
50,843 $2.3 Million
Q1 2022

May 03, 2022

SELL
$35.46 - $54.12 $166,945 - $254,796
-4,708 Reduced 7.36%
59,226 $3.01 Million
Q4 2021

Jan 31, 2022

BUY
$30.74 - $49.16 $622,485 - $995,489
20,250 Added 46.36%
63,934 $3.02 Million
Q3 2021

Oct 27, 2021

SELL
$31.4 - $69.84 $149,872 - $333,346
-4,773 Reduced 9.85%
43,684 $1.44 Million
Q2 2021

Jul 23, 2021

SELL
$40.9 - $64.9 $77,791 - $123,439
-1,902 Reduced 3.78%
48,457 $3.06 Million
Q1 2021

Apr 27, 2021

SELL
$40.8 - $57.39 $530,114 - $745,668
-12,993 Reduced 20.51%
50,359 $2.16 Million
Q4 2020

Feb 03, 2021

SELL
$30.79 - $57.2 $612,351 - $1.14 Million
-19,888 Reduced 23.89%
63,352 $3.62 Million
Q3 2020

Oct 27, 2020

BUY
$25.89 - $33.65 $586,926 - $762,845
22,670 Added 37.43%
83,240 $2.51 Million
Q2 2020

Aug 04, 2020

SELL
$24.8 - $38.49 $424,898 - $659,449
-17,133 Reduced 22.05%
60,570 $1.98 Million
Q4 2019

Jan 31, 2020

SELL
$22.1 - $30.8 $141,373 - $197,027
-6,397 Reduced 7.61%
77,703 $2.38 Million
Q3 2019

Oct 23, 2019

BUY
$24.09 - $32.18 $2.03 Million - $2.71 Million
84,100 New
84,100 $2.03 Million

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.84B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.